Overview of Stemetil INJ
| Property | Description |
|---|---|
| Active ingredient | Prochlorperazine |
| Form | Injectable Solution (Ampoule) |
| Pharmacological class | Phenothiazine Derivative (Antiemetic) |
| Common use | Acute Nausea, Vomiting, and Vertigo suppression |
| Origin | Synthetic |
What Type of Medicine is Stemetil INJ?
Stemetil INJ is a prescription-only medicine whose active component, Prochlorperazine, is a potent compound primarily used for its ability to control acute sickness. This substance is classified as a phenothiazine derivative, meaning it is a synthetic compound derived from the phenothiazine chemical structure. Prochlorperazine belongs to the pharmacological class of first-generation antipsychotics (or neuroleptics), but is clinically recognized for its targeted and effective properties as an antiemetic. This compound's robust action on the central nervous system provides a reliable solution for severe, acute symptoms, such as the spinning sensation experienced during a debilitating attack of vertigo.
Composition and the Meaning of the INJ Form
The designation INJ in Stemetil INJ is a key differentiator, confirming that this preparation is a sterile injectable solution intended for parenteral delivery, which includes both intramuscular and intravenous administration. The formulation contains the active ingredient Prochlorperazine, typically prepared as a soluble salt, such as Prochlorperazine mesylate or Prochlorperazine maleate, dissolved within a sterile aqueous vehicle suitable for injection. This specific liquid form is utilized when rapid action is necessary or when oral administration is impractical, a common scenario during continuous vomiting. The injectable route is utilized to achieve rapid systemic administration and the subsequent quick therapeutic effect required in acute care.
What is the General Purpose of Prochlorperazine?
The fundamental purpose of Prochlorperazine is to powerfully suppress the body's internal signals for sickness and dizziness by interrupting them at the source. The drug achieves its therapeutic effect by acting as a strong dopamine receptor antagonist, blocking the actions of dopamine in the brain. This central action directly affects the chemoreceptor trigger zone (CTZ), the specialized area of the brain responsible for initiating the vomiting reflex. By effectively silencing the CTZ, Prochlorperazine provides the general benefit of rapidly and reliably suppressing acute, severe nausea, vomiting, and spinning vertigo.
Regulatory References
